Recombinant Huntingtin Interacting Protein 2 (HIP2) Homo sapiens (Human) Recombinant protein

HYPG; LIG; UBE2K; Ubiquitin-Conjugating Enzyme E2K; Ubiquitin carrier protein; Ubiquitin-protein ligase

Add to Cart Distributors
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationCytoplasm
  • Molecular Mass 26.0kDa, Accurate 26kDa(Analysis of differences refer to the manual)
  • Residues & TagsAla2~Asn200 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 97%
  • Isoelectric Point5.3
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Huntingtin Interacting Protein 2 (HIP2) Packages (Simulation)
  • Recombinant Huntingtin Interacting Protein 2 (HIP2) Packages (Simulation)
  • RPE601Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • CSF Nrf2 and HSPA8 in Parkinson’s disease patients with and withoutPubMed: 26526034
  • CSF Nrf2 and HSPA8 in Parkinson&#039;s disease patients with and without LRRK2 gene mutationsPubMed: 26526034
  • Methylation‑associated silencing of miR‑128 promotes the development of esophageal cancer by targeting COX‑2 in areas with a high incidence of esophageal …Pubmed: 30535495

Recommend products